BioVaxys Technology Corp.
BVAXF • Biotechnology
$0.07
— 0.00 (0.00%)
Current price
EarningsLatest report: Jul 31, 2025
WEAK PROFILEWeakConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$2.03M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Weak liquidity · 0.4Weak profitability
Financial data as of: Jul 31, 2025, 12:00 AM UTCLast earnings update: Jul 31, 2025, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:36 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$0.07
Change0.00%
Shares Out29.15M
Market Cap$2.03M
52W Range0.02 - 0.30
Beta1.01
P/E-0.96
P/S0.00
P/B-0.96
P/FCF-3.30
EV/Sales0.00
EV/EBITDA0.00
Price$0.07
Change0.00%
Shares Out29.15M
Market Cap$2.03M
52W Range0.02 - 0.30
Beta1.01
P/E-0.96
P/S0.00
P/B-0.96
P/FCF-3.30
EV/Sales0.00
EV/EBITDA0.00
EV/FCF-8.61
Earnings Yield-26.07%
FCF Yield-30.27%
Dividend Yield0.00%
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq-0.04
Current Ratio0.40
Quick Ratio0.40
Volume1.38K
Avg Volume116.11K
Investment DNA
How strong this company looks for long-term investors
33
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
20/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
50/100
Why this score▼
Weak liquidity · 0.4Weak profitability
Analyst view
No analyst data available now.
🧾
No insider activity
No recent insider transactions available.